MedPath

Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men

Phase 1
Completed
Conditions
Hypogonadism
Registration Number
NCT00431197
Lead Sponsor
Mayo Clinic
Brief Summary

This study is being done to learn how the male hormone , testosterone, affects pituitary hormones in younger and older men. The pituitary is a gland in the brain that secretes hormones, some of which normally control growth and fertility.

Detailed Description

Concentrations of bioavailable testosterone decline by 1.0-1.5% annually as men age. Reduced systemic testosterone availability is associated with decreased muscle mass, strength and aerobic capacity, decreased bone-mineral density and increased risk of hip fracture, waning sexual interest, inpaired spatial cognition and increased risk of visceral obesity, impaired glucose tolerance and coronary artery disease. Luteinizing hormone (LH) secretion often fails in healthy older individuals. In addition, aging is marked by an acceleration of LH pulse frequency, loss of high-amplitude LH pulses and disorderly release of LH and testosterone, as measured by the approximate entropy statistic. The mechanisms that underlie such complex adaptations are not known, but appear to involve multiple loci of regulatory failure.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
LH and Testosterone levels will be evaluated after 4 study visits
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic and Foundation

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath